Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect

References

• Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;20:2698–704
   PubMed Web of Science ®Google Scholar
• Bricou A, Batt RE, Chapron C. Peritoneal fluid flow influences anatomical distribution of endometriotic lesions: why Sampson seems to be right. Eur J Obstet Gynecol Reprod Biol 2008;138:127–34
   PubMed Web of Science ®Google Scholar
• D’Hooghe TM, Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update 2002;8:84–8
   PubMed Web of Science ®Google Scholar
• Ozkan S, Arici A. Advances in treatment options of endometriosis. Gynecol Obstet Invest 2009;67:81–91
   PubMed Web of Science ®Google Scholar
• Rocha AL, Reis FM, Petraglia F. New trends for the medical treatment of endometriosis. Expert Opin Investig Drugs 2012; 21:905–19
   PubMed Web of Science ®Google Scholar
• Taylor HS, Osteen KG, Bruner-Tran KL, et al. Novel therapies targeting endometriosis. Reprod Sci 2011;18:814–23
   PubMed Web of Science ®Google Scholar
• Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549–80
   PubMed Web of Science ®Google Scholar
• Fasciani A, D’Ambrogio G, Bocci G, Monti M, Genazzani AR, Artini PG. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod 2000;6:50–4
   PubMed Web of Science ®Google Scholar
• Pupo-Nogueira A, de Oliveira RM, Petta CA, Podgaec S, Dias JA Jr, Abrao MS. Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis. Int J Gynaecol Obstet 2007;99:33–7
   PubMed Web of Science ®Google Scholar
• McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220–3
   PubMed Web of Science ®Google Scholar
• Cho S, Choi YS, Jeon YE, et al. Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis. Microvasc Res 2012;83:237–22
   PubMed Web of Science ®Google Scholar
• Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril 2000;73:166–70
   PubMed Web of Science ®Google Scholar
• Shifren JL, Tseng JF, Zaloudek CJ, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112–18
   PubMed Web of Science ®Google Scholar
• Becker CM, Rohwer N, Funakoshi T, et al. 2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol 2008;172:534–44
   PubMed Web of Science ®Google Scholar
• Semenza GL, Shimoda LA, Prabhakar NR. Regulation of gene expression by HIF-1. Novartis Found Symp 2006;272:2–8
   PubMedGoogle Scholar
• Greijer AE, van der Groep P, Kemming D, et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 2005;206:291–304
   PubMed Web of Science ®Google Scholar
• Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19:2003–12
   PubMed Web of Science ®Google Scholar
• Sato Y, Kanno S, Oda N, et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acad Sci 2000;902:201–5
   PubMed Web of Science ®Google Scholar
• Wieser F, Cohen M, Gaeddert A, et al. Evolution of medical treatment for endometriosis: back to the roots?Hum Reprod Update 2007;13:487–99
   PubMed Web of Science ®Google Scholar
• Flower A, Liu JP, Chen S, Lewith G, Little P. Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev 2009; 3:CD006568
   Google Scholar
• Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA 2008;105:4826–31
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang A, Sun H. Future perspectives of chinese medical formulae: chinmedomics as an effector. Omics 2012;16:414–21
   PubMed Web of Science ®Google Scholar
• Yavuz E, Oktem M, Esinler I, Toru SA, Zeyneloglu HB. Genistein causes regression of endometriotic implants in the rat model. Fertil Steril 2007;88:1129–34
   PubMed Web of Science ®Google Scholar
• Szymanowski K, Chmaj-Wierzchowska K, Yantczenko A, et al. Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model. Eur J Obstet Gynecol Reprod Biol 2009;142:145–8
   PubMed Web of Science ®Google Scholar
• Ji X, Gao J, Cai X, et al. Immunological regulation of Chinese herb Guizhi Fuling Capsule on rat endometriosis model. J Ethnopharmacol 2011;134:624–9
   PubMed Web of Science ®Google Scholar
• Olivares C, Ricci A, Bilotas M, Baranao RI, Meresman G. The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis. Fertil Steril 2011;96:428–33
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–8
   PubMed Web of Science ®Google Scholar
• Zhu YP, Woerdenbag HJ. Traditional Chinese herbal medicine. Pharm World Sci 1995;17:103–12
   PubMed Web of Science ®Google Scholar
• Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 2005;11:42–9
   PubMed Web of Science ®Google Scholar
• Burks-Wicks C, Cohen M, Fallbacher J, R NT, Wieser F. A Western primer of Chinese herbal therapy in endometriosis and infertility. Womens Health 2005;1:447–63
   Google Scholar
• Taylor RN, Mueller MD. Anti-angiogenic treatment of endometriosis: biochemical aspects. Gynecol Obstet Invest 2004;57:54–6
   PubMed Web of Science ®Google Scholar
• Al-Salam S, Balalaa N, Faour I, Akhter S, Alashari M. HIF-1alpha, VEGF and WT-1 are protagonists in bilateral primary angiosarcoma of breast: a case report and review of literature. Int J Clin Exp Pathol 2012;5:247–53
   PubMed Web of Science ®Google Scholar
• Chen P, Yin H, Wang Y, Wang Y, Xie L. Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1alpha in a mouse model of closed eye contact lens wear. Mol Vis 2012;18:864–73
   PubMed Web of Science ®Google Scholar
• Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling – in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359–71
   PubMed Web of Science ®Google Scholar
• Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49:568–81
   PubMed Web of Science ®Google Scholar
• Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000; 52:237–68
   PubMed Web of Science ®Google Scholar